Titan Biotech Board Meeting on Aug 13 to Approve Q1 FY27 Results

Titan Biotech Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Additionally, the meeting will address any other business as permitted by the Chairman. The company has also closed its trading window for designated persons from July 1, 2026, until 48 hours after the board meeting outcome is declared, in compliance with SEBI's insider trading regulations.